Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Therapie
|
October 2, 2015
Validation and Reproducibility of the Updated French Causality Assessment Method: an Evaluation by Pharmacovigilance Centres & Pharmaceutical Companies
Hélène Théophile, Jean-Paul Dutertre, Marie Gérardin, et al.
Therapie
|
February 14, 2015
Drugs and Sleep Apneas? A review of the French Pharmacovigilance database
Mélanie Linselle, François Montastruc, Hélène Jantzen, et al.
Therapie
|
April 3, 2023
Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspective
Francesco Salvo, Antoine Pariente, Marie Blanche Valnet-Rabier, et al.
JMIR Public Health and Surveillance
|
April 18, 2023
Safety Signal Generation for Sudden Sensorineural Hearing Loss Following Messenger RNA COVID-19 Vaccination: Postmarketing Surveillance Using the French Pharmacovigilance Spontaneous Reporting Database
Hung Thai-Van, Marie-Blanche Valnet-Rabier, Maëva Anciaux, et al.
Therapie
|
September 25, 2017
[Fibrates and risk of venous thromboembolism: Case/no-case study in French pharmacovigilance database]
Xavier Humbert, Charles Dolladille, Marion Sassier, et al.
Therapie
|
June 19, 2013
Updating the French method for the causality assessment of adverse drug reactions
Yannick Arimone, Irène Bidault, Jean-Paul Dutertre, et al.
Therapie
|
July 10, 2016
[Not Available]
, Yannick Arimone, Irène Bidault, et al.
Therapie
|
December 22, 2011
[Update of the French drug reaction assessment method]
, Yannick Arimone, Irène Bidault, et al.
Therapie
|
June 1, 2021
French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge
Clémence Lacroix, Francesco Salvo, Valérie Gras-Champel, et al.
Clinical Pharmacology and Therapeutics
|
December 3, 2021
Features of Inflammatory Heart Reactions Following mRNA COVID-19 Vaccination at a Global Level
Laurent Chouchana, Alice Blet, Mohammad Al-Khalaf, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Therapie
|
October 2, 2015
Validation and Reproducibility of the Updated French Causality Assessment Method: an Evaluation by Pharmacovigilance Centres & Pharmaceutical Companies
Hélène Théophile, Jean-Paul Dutertre, Marie Gérardin, et al.
Therapie
|
February 14, 2015
Drugs and Sleep Apneas? A review of the French Pharmacovigilance database
Mélanie Linselle, François Montastruc, Hélène Jantzen, et al.
Therapie
|
April 3, 2023
Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspective
Francesco Salvo, Antoine Pariente, Marie Blanche Valnet-Rabier, et al.
JMIR Public Health and Surveillance
|
April 18, 2023
Safety Signal Generation for Sudden Sensorineural Hearing Loss Following Messenger RNA COVID-19 Vaccination: Postmarketing Surveillance Using the French Pharmacovigilance Spontaneous Reporting Database
Hung Thai-Van, Marie-Blanche Valnet-Rabier, Maëva Anciaux, et al.
Therapie
|
September 25, 2017
[Fibrates and risk of venous thromboembolism: Case/no-case study in French pharmacovigilance database]
Xavier Humbert, Charles Dolladille, Marion Sassier, et al.
Therapie
|
June 19, 2013
Updating the French method for the causality assessment of adverse drug reactions
Yannick Arimone, Irène Bidault, Jean-Paul Dutertre, et al.
Therapie
|
July 10, 2016
[Not Available]
, Yannick Arimone, Irène Bidault, et al.
Therapie
|
December 22, 2011
[Update of the French drug reaction assessment method]
, Yannick Arimone, Irène Bidault, et al.
Therapie
|
June 1, 2021
French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge
Clémence Lacroix, Francesco Salvo, Valérie Gras-Champel, et al.
Clinical Pharmacology and Therapeutics
|
December 3, 2021
Features of Inflammatory Heart Reactions Following mRNA COVID-19 Vaccination at a Global Level
Laurent Chouchana, Alice Blet, Mohammad Al-Khalaf, et al.
Page
of 4